October was Good and November was Better
On November 1st, twenty-five shares of Gilead Sciences Inc. (GILD) were purchased for $79.29 per share totaling $1,982.25 in stock, and $60.15 in cash was left over (from the sale of the previous month's stock) equaling a grand total of $2,042.60 to start the month. Yesterday November 30th, the 25 shares were sold for $88.02 yielding $2,200.45 in proceeds. Combined with the leftover cash of $60.15, cash totals $2,260.60 heading into December. In August, I started with $2,005 so this trading strategy has returned 12.7 percent in just four months.
(adsbygoogle = window.adsbygoogle || []).push({});
For comparison, the S&P 500 exchange-traded index fund, SPY, returned negative 0.2 percent from August through November so our trading strategy continues to...